GB2069334B - Topical medicine containing indomethacin - Google Patents

Topical medicine containing indomethacin

Info

Publication number
GB2069334B
GB2069334B GB8102674A GB8102674A GB2069334B GB 2069334 B GB2069334 B GB 2069334B GB 8102674 A GB8102674 A GB 8102674A GB 8102674 A GB8102674 A GB 8102674A GB 2069334 B GB2069334 B GB 2069334B
Authority
GB
United Kingdom
Prior art keywords
medicine containing
containing indomethacin
topical medicine
topical
indomethacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8102674A
Other versions
GB2069334A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SOLVON ARZNEI VERTRIEB LIZENZ
Original Assignee
SOLVON ARZNEI VERTRIEB LIZENZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SOLVON ARZNEI VERTRIEB LIZENZ filed Critical SOLVON ARZNEI VERTRIEB LIZENZ
Publication of GB2069334A publication Critical patent/GB2069334A/en
Application granted granted Critical
Publication of GB2069334B publication Critical patent/GB2069334B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
GB8102674A 1980-02-18 1981-01-29 Topical medicine containing indomethacin Expired GB2069334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3006024A DE3006024C2 (en) 1980-02-18 1980-02-18 Topical medicinal product containing indomethacin in the form of an ointment

Publications (2)

Publication Number Publication Date
GB2069334A GB2069334A (en) 1981-08-26
GB2069334B true GB2069334B (en) 1983-10-19

Family

ID=6094913

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8102674A Expired GB2069334B (en) 1980-02-18 1981-01-29 Topical medicine containing indomethacin

Country Status (11)

Country Link
JP (1) JPS6024764B2 (en)
AT (1) AT373148B (en)
BE (1) BE887541A (en)
CH (1) CH645541A5 (en)
DE (1) DE3006024C2 (en)
ES (1) ES8201826A1 (en)
FR (1) FR2475897A1 (en)
GB (1) GB2069334B (en)
IT (1) IT1136564B (en)
NL (1) NL8100503A (en)
SE (1) SE447060B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5815940A (en) * 1981-07-23 1983-01-29 Eisai Co Ltd Polyprenyl compound, its preparation and drug containing the same
JPS59227818A (en) * 1983-06-09 1984-12-21 Mitsubishi Chem Ind Ltd Gel ointment
CH643138A5 (en) * 1983-08-29 1984-05-30 Mepha Ag INDOMETHACIN CONTAINING, gelatinous OINTMENT.
ATE57472T1 (en) * 1984-03-14 1990-11-15 Jerome Corbiere PROCESSES FOR DISSOLVING ACTIVE SUBSTANCES AND DRUGS OBTAINED IN THIS WAY.
JPS60224638A (en) * 1984-04-23 1985-11-09 Kao Corp Percutaneous absorption promoter and external drug containing same
JPH07112984B2 (en) * 1989-04-28 1995-12-06 久光製薬株式会社 Foam aerosol formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3624197A (en) * 1969-09-04 1971-11-30 Philip Schain Water-soluble tissue infiltrating and embedding compositions
BE756975A (en) * 1970-06-09 1971-04-02 Merck & Co Inc SUPPOSITORIES
US4011313A (en) * 1974-06-07 1977-03-08 Syntex (U.S.A.) Inc. Medicament preparations
JPS5320417A (en) * 1976-08-10 1978-02-24 Yamanouchi Pharmaceut Co Ltd New composition of preparation for rectal application
GB2023000B (en) * 1978-06-17 1982-10-13 Kowa Co Antinflammatory analgesic gelled ointments

Also Published As

Publication number Publication date
FR2475897A1 (en) 1981-08-21
IT1136564B (en) 1986-09-03
DE3006024C2 (en) 1983-08-04
FR2475897B1 (en) 1984-02-10
ES500421A0 (en) 1982-01-16
JPS56135413A (en) 1981-10-22
JPS6024764B2 (en) 1985-06-14
AT373148B (en) 1983-12-27
DE3006024A1 (en) 1981-08-20
SE8100623L (en) 1981-08-19
CH645541A5 (en) 1984-10-15
ES8201826A1 (en) 1982-01-16
BE887541A (en) 1981-06-15
ATA51381A (en) 1982-06-15
NL8100503A (en) 1981-09-16
IT8119824A0 (en) 1981-02-18
SE447060B (en) 1986-10-27
GB2069334A (en) 1981-08-26

Similar Documents

Publication Publication Date Title
IL63880A0 (en) Medicament containing 2-amino-6-trifluoromethoxy-benzothiazole
JPS57128622A (en) Nitroglycerin medicine medicine
AU550544B2 (en) Dosage unit
JPS5759804A (en) Alkalline analgesic capsule
JPS5786358A (en) Reservoir for medicine
JPS5764778A (en) Circular-arc display unit
GB2075458B (en) Encapsulation of indomethacin
JPS56139420A (en) Drug
JPS5775915A (en) Nasal medicine
JPS56150012A (en) Isotomic solution medicine
JPS56151052A (en) Dosage device
GB2067900B (en) Medicinal tablets
GB2069334B (en) Topical medicine containing indomethacin
ZA817443B (en) Tablet dispenser
ZA818221B (en) Pharmaceutical compounds
GB2072014B (en) Cosmetics containing 18-glycyrrhizins
PT73017A (en) Medicament container
MTP884B (en) Pharmaceutical preparationes
AU6978081A (en) Can carrying device
JPS57170258A (en) Therapeutic device enclosing container
JPS57106613A (en) Pharmacetical medicine
JPS56124299A (en) Device containing structure
JPS56127313A (en) Medicine containing naphthyridine derivative
JPS57123200A (en) Aminopapulacandin derivative, manufacture and medicine containing same
JPS57153661A (en) Therapeutic container

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee